Taken together, the data establish that the in vivo activity of CYC065 against MYCN-dependent NB tumor progression proceeds largely through transcriptional depletion of MYCN, leading to increased apoptosis and rapid loss of tumor burden. The gene discussed is MYCN; the disease is neoplasm.